Steroids and Progestins

The incidence of cancer-associated anorexia and cachexia (25% to 90%) makes it a significant burden on patients, their families and the health care system.1–5 It is impdrtant to consider both the medical and psychosocial aspects of this problem when a treatment strategy is being developed. Devising a nutrition plan that is comprehensive, acceptable and cost effective is challenging. This is particularly difficult when food aversions and taste change may have developed. In addition, there are often other symptoms which contribute to anorexia and must be controlled.5–8 The most successful plan will include nonpharmacologic interventions9 and be flexible enough to incorporate the patients preferences and withstand frequent changes in their condition.